Cargando…

Usefulness Differs Between the Visual Assessment and Specific Binding Ratio of (123)I-Ioflupane SPECT in Assessing Clinical Symptoms of Drug-Naïve Parkinson’s Disease Patients

Background: In clinical practice, assessment of the striatal accumulation in (123)I-ioflupane single photon emission computed tomography (SPECT) is commonly performed calculating the specific binding ratio (SBR) for the whole striatum. On the other hand, visual assessment of striatal accumulation in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Hidetomo, Kimura, Atsushi, Yasumoto, Taro, Miki, Ayako, Yamamoto, Ken, Ito, Naohito, Momma, Yutaro, Owan, Yoshiyuki, Yano, Satoshi, Ono, Kenjiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306624/ https://www.ncbi.nlm.nih.gov/pubmed/30618718 http://dx.doi.org/10.3389/fnagi.2018.00412

Ejemplares similares

Accumulation of (123)I-Ioflupane Is a Useful Marker of the Efficacy of Selegiline Monotherapy in Drug-Naïve Parkinson’s Disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

CT-Based Attenuation Correction in I-123-Ioflupane SPECT
por: Lange, Catharina, et al.
Publicado: (2014)

Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses
por: Badoud, Simon, et al.
Publicado: (2016)

Correlated levels of cerebrospinal fluid pathogenic proteins in drug-naïve Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2019)

Bipolar Disorder and Parkinson's Disease: A (123)I-Ioflupane Dopamine Transporter SPECT Study
por: Erro, Roberto, et al.
Publicado: (2021)

(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017)

The role of (123)I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies
por: Antonini, Angelo
Publicado: (2007)

Impact of the cerebrospinal fluid-mask algorithm on the diagnostic performance of (123)I-Ioflupane SPECT: an investigation of parkinsonian syndromes
por: Iwabuchi, Yu, et al.
Publicado: (2019)

Diagnostic Effectiveness of [(123)I]Ioflupane Single Photon Emission Computed Tomography (SPECT) in Multiple System Atrophy
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Importance of (123)I-ioflupane SPECT and Myocardial MIBG Scintigraphy to Determine the Candidate of Deep Brain Stimulation for Parkinson’s Disease
por: ASAHI, Takashi, et al.
Publicado: (2016)

Robust Ensemble Classification Methodology for I123-Ioflupane SPECT Images and Multiple Heterogeneous Biomarkers in the Diagnosis of Parkinson's Disease
por: Castillo-Barnes, Diego, et al.
Publicado: (2018)

Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ((123)I) ioflupane in diagnosis of parkinsonian syndromes
por: Bajaj, Nin, et al.
Publicado: (2013)

Clinical Comparison of (99m)Tc Exametazime and (123)I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain Injury
por: Newberg, Andrew B., et al.
Publicado: (2014)

Reduced 123I Ioflupane Binding in Bilateral Diabetic Chorea: Findings With 18F FDG PET, 99mTc ECD SPECT, and 123I MIBG Scintigraphy
por: Sato, Kenichiro, et al.
Publicado: (2016)

Patient Survey on Satisfaction and Impact of 123I-Ioflupane Dopamine Transporter Imaging
por: Covington, Matthew F., et al.
Publicado: (2015)

Interpreting (123)I–ioflupane dopamine transporter scans using hybrid scores
por: Nichols, Kenneth J., et al.
Publicado: (2018)

Safety, biodistribution and radiation dosimetry of [(123)I]ioflupane in healthy Chinese volunteers
por: Zhang, Min, et al.
Publicado: (2023)

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
por: Murakami, Hidetomo, et al.
Publicado: (2017)

Diagnosis of Parkinson syndrome and Lewy-body disease using (123)I-ioflupane images and a model with image features based on machine learning
por: Nakajima, Kenichi, et al.
Publicado: (2022)

Japanese multicenter database of healthy controls for [(123)I]FP-CIT SPECT
por: Matsuda, Hiroshi, et al.
Publicado: (2018)

Follow-Up Findings in Multiple System Atrophy from [(123)I]Ioflupane Single-Photon Emission Computed Tomography (SPECT): A Prospective Study
por: Villena-Salinas, Javier, et al.
Publicado: (2023)

Rest Tremor Pattern Predicts DaTscan ( (123)I‐Ioflupane) Result in Tremulous Disorders
por: Quattrone, Andrea, et al.
Publicado: (2021)

Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Correction: Comparison between Different Intensity Normalization Methods in (123)I-Ioflupane Imaging for the Automatic Detection of Parkinsonism
por: Brahim, A., et al.
Publicado: (2015)

Association between body mass index (BMI) and [(123)I]Ioflupane (DaTSCAN) availabilities in patients with parkinsonism using single-photon emission computed tomography–computed tomography (SPECT-CT)
por: Parekh, Puja, et al.
Publicado: (2023)

Neuroprotective Potential of Raloxifene via G-Protein-Coupled Estrogen Receptors in Aβ-Oligomer-Induced Neuronal Injury
por: Nohara, Tetsuhito, et al.
Publicado: (2023)

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials
por: O'Brien, John T, et al.
Publicado: (2014)

Combined Treatment with Curcumin and Ferulic Acid Suppressed the Aβ-Induced Neurotoxicity More than Curcumin and Ferulic Acid Alone
por: Ohashi, Hideaki, et al.
Publicado: (2022)

The Curcumin Derivative GT863 Protects Cell Membranes in Cytotoxicity by Aβ Oligomers
por: Momma, Yutaro, et al.
Publicado: (2023)

Striatal dopamine D(2/3) receptors in medication-naïve schizophrenia: an [(123)I] IBZM SPECT study
por: Chen, Kao Chin, et al.
Publicado: (2022)

Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions
por: van der Veen, Berlinda J., et al.
Publicado: (2012)

Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease
por: Suwijn, Sven R., et al.
Publicado: (2019)

Optic Nerve Tortuosity in Idiopathic Intracranial Hypertension
por: Hieda, Sotaro, et al.
Publicado: (2020)

Development of Novel (123)I-Labeled Pyridyl Benzofuran Derivatives for SPECT Imaging of β-Amyloid Plaques in Alzheimer’s Disease
por: Ono, Masahiro, et al.
Publicado: (2013)

A new visual rating scale for Ioflupane imaging in Lewy body disease
por: Lloyd, Jim J., et al.
Publicado: (2018)

Loss of thalamic serotonin transporters in early drug-naïve Parkinson’s disease patients is associated with tremor: an [(123)I]β-CIT SPECT study
por: Caretti, V., et al.
Publicado: (2008)

Assessment of Motor Dysfunction with Virtual Reality in Patients Undergoing [(123)I]FP-CIT SPECT/CT Brain Imaging
por: Vu, Jeanne P., et al.
Publicado: (2021)

Differential Effects of the Factor Structure of the Wechsler Memory Scale-Revised on the Cortical Thickness and Complexity of Patients Aged Over 75 Years in a Memory Clinic Setting
por: Kinno, Ryuta, et al.
Publicado: (2017)

[(123)I]-Celecoxib Analogues as SPECT Tracers of Cyclooxygenase-2 in Inflammation
por: Uddin, Md. Jashim, et al.
Publicado: (2010)

Clinicopathological and (123)I‐FP‐CIT SPECT correlations in patients with dementia
por: Jung, Youngsin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_spgjkjoa7vn963vg2m5qgj7bk3